M Gou, Y Zhang, H Si, G Dai - OncoTargets and therapy, 2019 - Taylor & Francis
Objective PD-1 inhibitors have improved efficacy in many cancers. There are currently no
reports of the use of PD-1 inhibitors, such as nivolumab, for metastatic biliary tract cancer …